Prab: CSV import

2025-03-17T08:44:10Z

CSV import

← Older revision		Revision as of 08:44, 17 March 2025
Line 38:		Line 38:
	{{No image}}		{{No image}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T13:49:40Z

CSV import

← Older revision		Revision as of 13:49, 10 February 2025
Line 36:		Line 36:
	[[Category:Drug Delivery Systems]]		[[Category:Drug Delivery Systems]]
	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}
	{{No image}}		{{No image}}

Prab: CSV import

2025-02-10T13:45:19Z

CSV import

← Older revision		Revision as of 13:45, 10 February 2025
Line 36:		Line 36:
	[[Category:Drug Delivery Systems]]		[[Category:Drug Delivery Systems]]
	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-27T00:01:35Z

CSV import

New page

'''Delayed Release''' refers to a [[pharmaceutical]] formulation technology that allows the release of a [[drug]] into the [[digestive system]] at a time other than immediately after administration. This technology is used to improve the efficacy and decrease the side effects of various medications. Delayed release systems are designed to release the active ingredient of the medication at a specific time or location in the [[gastrointestinal tract]] (GIT), often to target the site where the drug is most absorbed or to protect the drug from the acidic environment of the stomach.

==Overview==
Delayed release formulations are a critical component in the field of [[pharmacology]] and [[drug delivery systems]]. These formulations are engineered to release the active pharmaceutical ingredient (API) at a specific time after ingestion, which can be crucial for drugs that are sensitive to the acidic conditions of the stomach or are intended to act in parts of the GIT beyond the stomach. The primary goal of delayed release technology is to enhance the therapeutic effectiveness and safety profile of medications.

==Mechanisms of Delayed Release==
The mechanisms employed in delayed release formulations can vary, but they generally involve coatings or matrices that protect the drug from the stomach's acidic environment, controlling the drug's release rate. These can include:

* '''Enteric Coatings''': These are pH-sensitive coatings that remain intact in the acidic environment of the stomach but dissolve in the more neutral to alkaline conditions of the small intestine, releasing the drug.
* '''Matrix Systems''': These involve embedding the drug in a matrix that dissolves or erodes over time, controlling the release rate of the drug.

==Applications==
Delayed release formulations have a wide range of applications in medical treatment, including:

* Enhancing the bioavailability of drugs that are unstable in the acidic conditions of the stomach.
* Reducing side effects associated with the drug's release in the stomach.
* Targeting the release of drugs to specific areas within the GIT for localized treatment or improved absorption.
* Improving patient compliance by reducing the frequency of dosing.

==Advantages and Disadvantages==
'''Advantages:'''
* Improved drug stability and bioavailability.
* Reduced gastrointestinal side effects.
* Targeted drug delivery and action.
* Enhanced patient compliance.

'''Disadvantages:'''
* Complexity and cost of formulation development.
* Potential for interpatient variability in drug release and absorption.
* Challenges in predicting the precise timing of drug release.

==Conclusion==
Delayed release formulations represent a significant advancement in drug delivery technology, offering numerous benefits in terms of drug stability, efficacy, and patient compliance. However, the development of these formulations requires careful consideration of the drug's properties, the target site of action, and the intended release profile to achieve the desired therapeutic outcomes.

[[Category:Pharmaceutical Sciences]]
[[Category:Drug Delivery Systems]]
{{medicine-stub}}

Delayed release - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import

Prab: CSV import